Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2003
05/15/2003WO2003039616A1 Percutaneous transluminal drug delivery device
05/15/2003WO2003039595A2 Mucosal adjuvants comprising an oligonucleotide and a cationic lipid
05/15/2003WO2003039593A1 Fowl adenovirus vaccine
05/15/2003WO2003039584A1 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides
05/15/2003WO2003039574A1 Endophilin homologous proteins involved in the regulation of energy homeostasis
05/15/2003WO2003039555A2 Agents for treating lesions of the nervous system
05/15/2003WO2003039523A2 OLIGONUCLEOTIDES MODIFIED WITH NOVEL α-L-RNA ANALOGUES
05/15/2003WO2003039491A2 Novel isoforms of vascular endothelial cell growth inhibitor
05/15/2003WO2003039484A2 Novel compositions and methods for cancer
05/15/2003WO2003039476A2 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874
05/15/2003WO2003039475A2 Methods of identifying and using modulators of fractalkine receptor
05/15/2003WO2003039471A2 Catalytic antibodies raised against sarin and process for the preparation thereof
05/15/2003WO2003039462A2 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
05/15/2003WO2003039459A2 Viral vector production methods and compositions
05/15/2003WO2003039458A2 TREATMENT OF HUMAN CANCER WITH ADENOVIRAL VECTOR EXPRESSING TNF-α
05/15/2003WO2003039438A2 Pna-conjugates for treating chronic myeloid leukaemia (cml)
05/15/2003WO2003039346A2 Diagnostics and therapeutics for ocular abnormalities
05/15/2003WO2003039344A2 Methods and compositions for correction of cardiac conduction disturbances
05/15/2003WO2003039342A2 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145
05/15/2003WO2003039341A2 Methods and compositions to treat cardiovascular disease using 139, 258, 1261, 1486, 2398, 2414, 7660, 8587, 10183, 10550, 12680, 17921, 32248, 60489 or 93804
05/15/2003WO2003039245A2 Transgenic mice knockout for histamine receptor h3 gene
05/15/2003WO2003039243A2 Amine oxidase stress-related polypeptides and methods of use in plants
05/15/2003WO2003039226A2 Front opening body armor
05/15/2003WO2003025171A3 Modulation of retinoic acid receptor gene expression and therapeutic uses thereof
05/15/2003WO2003020754A3 Inhibition of replication factor c
05/15/2003WO2003004626A3 A bioprocess for the generation of cells derived from spheroid-forming cells
05/15/2003WO2002097032A3 Proteins associated with cell growth, differentiation, and death
05/15/2003WO2002088318A3 Lipid-comprising drug delivery complexes and methods for their production
05/15/2003WO2002088315A3 Phagemid vectors
05/15/2003WO2002083179A3 Fusion proteins
05/15/2003WO2002068657A3 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
05/15/2003WO2002068637A8 Nucleic acid-based treatment of diseases or conditions related to west nile virus infection
05/15/2003WO2002064795A3 Putative human enzymes
05/15/2003WO2002063003A3 Platlet glycoprotein ib alpha fusion polypeptides and methods of use thereof
05/15/2003WO2002063001A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
05/15/2003WO2002061148A3 Circulating epstein-barr virus dna in the serum of patients with gastric carcinoma
05/15/2003WO2002061130A3 Methods and reagents for analysis of rna structure and function
05/15/2003WO2002057486A3 Dual fidelity erca detection systems
05/15/2003WO2002057451A9 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein
05/15/2003WO2002056027A3 Regulation of neutral development by daedalos
05/15/2003WO2002055108A9 Targeted modification of intracellular compounds
05/15/2003WO2002053718A3 Isolated human phosphodiesterase proteins, nucleic acid molecules encoding human phosphodiesterase proteins, and uses thereof
05/15/2003WO2002048366A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/15/2003WO2002048365A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/15/2003WO2002048364A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/15/2003WO2002042482A3 Functional lentiviral vector from an mlv-based backbone
05/15/2003WO2002040655A3 Phospholipase a2 group preferentially expressed in th2 cells
05/15/2003WO2002040654A3 A human serpin secreted from lymphoid cells lsi-01
05/15/2003WO2002038606A3 Compositions and methods relating to ovary specific genes and proteins
05/15/2003WO2002034034A8 Transgenic plants with reduced expression of endogenous phytochrome a, exhibiting improved rooting, and methods for their production
05/15/2003WO2002030462A9 Hedgehog antagonists, methods and uses related thereto
05/15/2003WO2002029059A9 Nogo receptor homologs
05/15/2003WO2002029031A3 Isoprenoid-dependent ras anchorage (idra) proteins
05/15/2003WO2002029025A9 Factor vii glycoforms
05/15/2003WO2002026987A3 A human g-protein coupled receptor, hgprbmy6, expressed highly in small intestine
05/15/2003WO2002026981A3 Human protease inhibitor proteins and polynucleotides encoding the same
05/15/2003WO2002026959A3 Nuclear reprogramming using iwsi and related chromatin remodeling atpases
05/15/2003WO2002026754A9 Oligonucleotides, agents containing these oligonucleotides, and the use thereof
05/15/2003WO2002024913A3 32612, a novel human peptide transporter and uses therefor
05/15/2003WO2002018424A3 Nucleic acids and polypeptides
05/15/2003WO2002018407A9 Antisense oligonucleotides against vanilloid receptor 1
05/15/2003WO2002016600A3 Novel proteins and nucleic acids encoding same
05/15/2003WO2002014348A3 Glycoproteins and methods of use thereof
05/15/2003WO2002012475A3 C1q-related factor, homologous polypeptides and therapeutic uses thereof
05/15/2003WO2002009509A3 Inhibition of gene expression using polynucleotide analogues
05/15/2003WO2002006448A3 Transformation systems for flavinogenic yeast
05/15/2003US20030093842 Use of a sulphonamide resistance gene as a selectable marker in a monocot species
05/15/2003US20030093840 Bombarding cells prepared from non- embryo Brassica tissue with nucleic acid-coated microprojectiles to form a bombarded cell preparation; identifying cells of bombarded preparation that have been transformed with nucleic acid
05/15/2003US20030093839 For preparing transgenic plant cells and plants; specific gene expression in the guard cell of the leaves of plants, and no expression in mesophyllic cells or epidermal cells of the leaves
05/15/2003US20030093837 Polynucleotides for seed trait alteration
05/15/2003US20030093836 Reduction of in planta degradation of recombinant plant products
05/15/2003US20030093835 Chimeric genes controlling flowering
05/15/2003US20030093834 Nucleic acid molecules encoding wheat enzymes involved in starch synthesis
05/15/2003US20030093833 Stress tolerant plants
05/15/2003US20030093832 Methods for the production of multimeric immunoglobulins, and related compositions
05/15/2003US20030093831 Methods of using viral replicase polynucleotides and polypeptides
05/15/2003US20030093830 Means for identifying the locus of a major resistance gene to the rice yellow mottle virus, and their applications
05/15/2003US20030093829 Doubled haploid production and genetic transformation
05/15/2003US20030093828 Seed specific 7Salpha promoter for expressing genes in plants
05/15/2003US20030093827 For producing a transgenic plant; seeds
05/15/2003US20030093825 Putative neurotransmitter receptor (PNR) disruptions, compositions and methods relating thereto
05/15/2003US20030093824 SPC6 serine protease gene disruptions, and compositions and methods related thereto
05/15/2003US20030093823 Transgenic mice containing lumulus clotting factor protease-like gene disruptions
05/15/2003US20030093822 Transgenic animal model of neurodegenerative disorders
05/15/2003US20030093821 For therapy of human subject diagnosed for predisposition for increased serum cholesterol or LDL cholesterol
05/15/2003US20030093820 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
05/15/2003US20030093819 Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereof
05/15/2003US20030093818 Transgenic animals comprising a humanized immune system
05/15/2003US20030093227 Statistical combining of cell expression profiles
05/15/2003US20030092899 Polynucleotide functionally coding for the LHP protein from Mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same
05/15/2003US20030092897 Antigen composition against mycoplasma
05/15/2003US20030092893 Antibody for use in the diagnosis of cancer, reproductive, kidney and nervous system disorders
05/15/2003US20030092892 Crosslinking, agglutination, purification
05/15/2003US20030092891 Expressed ligand - vascular intercellular signalling molecule
05/15/2003US20030092882 Host cells containing multiple integrating vectors
05/15/2003US20030092881 Polypeptide for use in diagnosis and treatment of gastrointestinal disorders
05/15/2003US20030092665 Methods and compositions for administering DNA to mucosal surfaces
05/15/2003US20030092662 Molecular interaction sites of 16S ribosomal RNA and methods of modulating the same
05/15/2003US20030092659 Therapy for nervous system degradation
05/15/2003US20030092656 Therapeutic agents for treatment of solid tumors comprising an expression-inhibiting sustance against Wilms' tumor gene (WT1)
1 ... 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 ... 4023